PODD Insulet Corporation
Healthcare$154.87+0.00%OpenMarket Cap: $10.73B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$232.18
Target (Median)
$237.00
Target Range
$198.00 - $280.00
Upside from current price: 49.9%
Rating Distribution
5 Strong Buy17 Buy3 Hold0 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-18 | B of A Securities | maintain | Buy | Buy |
| 2026-05-08 | Barclays | maintain | Underweight | Underweight |
| 2026-05-07 | Truist Securities | maintain | Buy | Buy |
| 2026-05-07 | Bernstein | maintain | Outperform | Outperform |
| 2026-05-07 | Canaccord Genuity | maintain | Buy | Buy |
| 2026-05-07 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-05-07 | JP Morgan | maintain | Overweight | Overweight |
| 2026-05-07 | Wells Fargo | maintain | Overweight | Overweight |
| 2026-05-07 | RBC Capital | maintain | Outperform | Outperform |
| 2026-05-07 | Oppenheimer | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $8.14 | $3.96B | 15 |
| Sun Dec 31 | $10.25 | $4.69B | 7 |
| Mon Dec 31 | $12.64 | $5.47B | 2 |
| Tue Dec 31 | $14.49 | $6.10B | 5 |